iDose TR is an innovative implant designed to manage glaucoma and ocular hypertension by delivering medication directly to the eye. This treatment simplifies glaucoma management, offering long-lasting pressure control without the hassle of daily eye drops.
iDose TR is a small implant that helps treat open-angle glaucoma and ocular hypertension by slowly releasing medication inside the eye to lower pressure. This innovative treatment reduces or eliminates the need for daily eye drops, offering long-lasting relief and helping protect your vision over time.
iDose TR delivers glaucoma medication using a tiny implant placed in the eye, steadily releasing the drug travoprost for up to three years. It simplifies glaucoma management by providing consistent medication without daily drops.
Traditional glaucoma treatments require daily eye drops, which many patients forget or struggle to manage. iDose TR automatically provides a steady dose, improving eye pressure control and reducing fluctuations often seen with drops.
The implant is made of medical-grade titanium with a special membrane controlling the gradual release of travoprost. It is placed in the eye’s drainage system, enhancing fluid outflow and lowering eye pressure by approximately 30% on average in clinical studies.
Developed by Glaukos Corporation, iDose TR was approved by the FDA in 2023 for adults with open-angle glaucoma or ocular hypertension. It addresses patient and doctor frustrations with traditional drop regimens by providing a seamless, long-term therapy.
Large studies have demonstrated the safety and effectiveness of iDose TR in lowering intraocular pressure. Long-term data show promising device retention, clinical benefits, and minimal complications.
iDose TR uniquely targets the trabecular meshwork, the eye’s natural drainage pathway, delivering medication precisely where it is most effective, setting it apart from other glaucoma implants.
The implant is inserted into the eye and releases medication steadily to maintain stable eye pressure without the hassle of drops.
The procedure is quick, usually under 30 minutes, performed with local numbing drops to ensure comfort. The implant is carefully placed in the trabecular meshwork via advanced tools during an outpatient visit.
Once implanted, iDose TR gradually releases travoprost, improving fluid drainage and providing consistent intraocular pressure control, avoiding spikes or drops common with traditional therapies.
The implant typically delivers medication for 2 to 3 years before it may need replacement or removal during a similar outpatient procedure.
Regular follow-up visits with your ophthalmologist are important to monitor eye pressure and implant function, including specialized imaging if needed.
iDose TR offers multiple advantages that improve convenience, control, and quality of life for glaucoma patients.
By automatically delivering medication, iDose TR eliminates the need for daily drops, reducing pharmacy visits and the risk of missed doses.
Steady medication release results in more stable eye pressure, which can slow glaucoma progression and better protect vision.
Consistent treatment reduces the risk of vision loss over time and can be especially beneficial for those with difficulty adhering to drop regimens.
Since medication is delivered directly inside the eye, many common eye drop side effects such as irritation or allergic reactions are minimized.
iDose TR may reduce or eliminate the need for additional glaucoma medications, simplifying the treatment regimen.
Patients can travel, exercise, and sleep without the burden of managing multiple eye drops throughout the day.
This treatment is suitable for many adults with open-angle glaucoma or ocular hypertension and is worth discussing with your eye doctor.
Those using drops with busy lifestyles, difficulty remembering medication, or intolerant to drop side effects often benefit most from iDose TR.
Primarily used for open-angle glaucoma and ocular hypertension to protect the optic nerve by lowering eye pressure.
Not suitable for patients with certain eye infections, allergies to travoprost, narrow-angle glaucoma, or pregnant/nursing women.
Your doctor will evaluate your medical history and eye health to determine if iDose TR is an appropriate option.
The procedure is a quick outpatient visit that allows most patients to go home the same day.
Your doctor will provide instructions ahead of time, including possible medication adjustments and arranging for transportation post-procedure if needed.
Your eye will be numbed, and a small opening made for implant placement into the trabecular meshwork with minimal discomfort.
Rest and use prescribed eye drops to prevent infection. Avoid rubbing your eye and heavy lifting for a few days. Follow-up visits ensure proper healing and implant function.
Mild irritation or temporary blurry vision may occur but usually resolves quickly. Normal activities can typically resume within a few days.
Take control of your glaucoma management with iDose TR and explore options offered by top ophthalmologists listed with Specialty Vision. Schedule a consultation today to discuss how iDose TR may enhance your treatment plan!
Like any medical treatment, iDose TR has some risks, but most are mild and manageable.
Temporary redness, irritation, or blurred vision may be experienced shortly after the procedure and usually improve within days.
Rare complications like infection, inflammation, or implant displacement can occur but are typically treatable when caught early.
Contact your eye care provider promptly if severe pain, vision changes, or signs of infection arise. Most patients tolerate the implant well.
Patients typically adjust quickly to the implant. Regular check-ups help monitor any subtle changes and ensure ongoing visual function.
iDose TR represents a significant advancement in glaucoma care that may simplify treatment and protect your vision. Consult with your eye doctor to see if it is right for you.
Take control of your glaucoma management with iDose TR and explore options offered by top ophthalmologists listed with Specialty Vision. Schedule a consultation today to discuss how iDose TR may enhance your treatment plan!
iDose TR offers innovative glaucoma treatment through a small implant, simplifying medication management and improving eye pressure control.
